skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma

Original Research

(6055) Views  (1120) Full article downloads

Authors: Dimitris Papaconstantinou, Ilias Georgalas, George Kalantzis, Efthimios Karmiris, et al.

Published Date March 2009 Volume 2009:3 Pages 251 - 257
DOI: http://dx.doi.org/10.2147/OPTH.S5194

Dimitris Papaconstantinou1, Ilias Georgalas2, George Kalantzis1, Efthimios Karmiris1, Chrysanthi Koutsandrea1, Andreas Diagourtas1, Ioannis Ladas1, Gerasimos Georgopoulos1

1Department of Ophthalmology, University of Athens, Athens, Greece; 2“G Genimatas” Hospital, NHS, Athens, Greece

Purpose: To study acquired color vision and visual field defects in patients with ocular hypertension (OH) and early glaucoma.

Methods: In a prospective study we evaluated 99 eyes of 56 patients with OH without visual field defects and no hereditary color deficiencies, followed up for 4 to 6 years (mean = 4.7 ± 0.6 years). Color vision defects were studied using a special computer program for Farnsworth–Munsell 100 hue test and visual field tests were performed with Humphrey analyzer using program 30–2. Both tests were repeated every six months.

Results: In fifty-six eyes, glaucomatous defects were observed during the follow-up period. There was a statistically significant difference in total error score (TES) between eyes that eventually developed glaucoma (157.89 ± 31.79) and OH eyes (75.51 ± 31.57) at the first examination (t value 12.816, p < 0.001). At the same time visual field indices were within normal limits in both groups. In the glaucomatous eyes the earliest statistical significant change in TES was identified at the first year of follow-up and was –20.62 ± 2.75 (t value 9.08, p < 0.001) while in OH eyes was −2.11 ± 4.36 (t value 1.1, p = 0.276). Pearson’s coefficient was high in all examinations and showed a direct correlation between TES and mean deviation and corrected pattern standard deviation in both groups.

Conclusion: Quantitative analysis of color vision defects provides the possibility of follow-up and can prove a useful means for detecting early glaucomatous changes in patients with normal visual fields.

Keywords: color vision defects, glaucoma, hereditary, vision field






 

Other articles by Dr Ilias Georgalas

A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
Angioid streaks, clinical course, complications, and current therapeutic management
Contemporary aspects in the prognosis of traumatic hyphemas
Cytomegalovirus retinitis presenting as vasculitis in a patient with Wegener’s granulomatosis
Foveal thickness after phacoemulsification as measured by optical coherence tomography
Lens-induced glaucoma in the elderly
Nd: YAG capsulotomy for posterior capsule opacification after combined clear corneal phacoemulsification and vitrectomy
Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex
Preliminary results following the use of a fixed combination of timolol–brimonidine in patients with ocular hypertension and primary open-angle glaucoma
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab


Readers of this article also read:

Recognition of transorbital intracranial injury ||FREE PAPER||
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
Preliminary results following the use of a fixed combination of timolol–brimonidine in patients with ocular hypertension and primary open-angle glaucoma
Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
Insight into 144 patients with ocular vascular events during VEGF antagonist injections
Lamellar macular hole formation following vitrectomy for rhegmatogenous retinal detachment repair
Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression: does venooclusive disease predispose to cytomegalovirus retinitis in patients already at risk?